Clinical Trials Browser

Phase 1 × Hodgkin Disease × 30 days × Clear all

NCT01333046 2026-06-03

TACTAL

Phase 1 Active not recruiting

Hodgkin Disease, Lymphoma, Non-Hodgkin

NCT07623850 2026-06-03

JLM019

Phase 1 Recruiting

Hodgkin Disease, Lymphoma, Non-Hodgkin

NCT01087294 2026-06-01

Administration of Anti-CD19-chimeric-antigen-receptor-transduced T Cells From the Original Transplant Donor to Patients With Recurrent or Persistent B-cell Malignancies After Allogeneic Stem Cell Transplantation

Phase 1 Completed

LymphoidOther hematologic neoplasm

Hodgkin Disease, Lymphoma, Non-Hodgkin, Leukemia, B-Cell, Lymphoma, B-Cell

NCT04640779 2026-05-28

Low-Dose Selinexor and Choline Salicylate for Non-Hodgkin or Hodgkin Lymphoma, Histiocytic/Dendritic Cell Neoplasm, or Relapsed or Refractory Multiple Myeloma

Phase 1 Completed

LymphoidPlasma cell

Hodgkin Disease, Lymphoma, Non-Hodgkin, Multiple Myeloma